{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:45:35Z","timestamp":1783719935452,"version":"3.55.0"},"reference-count":51,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100023993","name":"North Carolina Policy Collaboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In the United States, methadone for opioid use disorder is limited to opioid treatment programs. Increased methadone access is necessary, and community pharmacies may be a logical option for expansion. The objectives of this study were to explore opioid treatment program (OTP) staff members\u2019 perceptions of and anticipated barriers and facilitators to implementing pharmacy-based methadone dispensing via medication units.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Participants in this study were purposively sampled from OTP staff in North Carolina who completed a previous quantitative survey on the perceived acceptability, appropriateness, and feasibility of pharmacy-based methadone dispensing and agreed to be contacted for an interview. Thematic analysis was conducted to identify salient and main themes, and relationships among and between themes, as well as areas of divergence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>OTP staff (n\u2009=\u200910) endorsed increased access and OTP-pharmacy collaboration as benefits of pharmacy-based methadone dispensing. OTP staff were concerned about community pharmacy stigma, the suitability of the pharmacy setting for methadone treatment, and loss of counseling and felt that lack of pharmacy interest would be a barrier to implementation. OTP staff identified 5 implementation facilitators, including OTP willingness and pharmacist capability to provide the service, telehealth, clear communication, and reimbursement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Results from this study demonstrate moderate interest from OTP staff towards pharmacy-based methadone dispensing. Researchers and other vested parties should consider conducting a pilot study to identify how best to implement medication units in the pharmacy setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29767342261449037","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T07:40:03Z","timestamp":1780213203000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Expanding Methadone Access Through Community Pharmacies: A Qualitative Study Exploring Opioid Treatment Program Staff Perceptions of Pharmacy-Based Medication Units"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8044-9838","authenticated-orcid":false,"given":"Caroline","family":"Shubel","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Asheville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ava","family":"Nunnery","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Asheville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-0631","authenticated-orcid":false,"given":"Grace T.","family":"Marley","sequence":"additional","affiliation":[{"name":"UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA"},{"name":"South East Area Health Education Center, Wilmington, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-8140","authenticated-orcid":false,"given":"Delesha M.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Asheville, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-3747","authenticated-orcid":false,"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[{"name":"Fruit of Labor Action Research &amp; Technical Assistance, LLC, Marshall, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"NC Department of Health and Human Services Division of Public Health Injury & Violence Prevention Branch. \u201cNorth Carolina Overdose Epidemic Data | Division of Public Health.\u201d North Carolina Overdose Epidemic Data. Accessed November 1 2025. https:\/\/www.dph.ncdhhs.gov\/ivpb-overdose-data"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694598"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15814"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108686"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.16954"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1511"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102844"},{"key":"e_1_3_3_10_2","unstructured":"SAMHSA. Opioid treatment program directory. Accessed October 2025. https:\/\/dpt2.samhsa.gov\/treatment\/"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100138"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306665"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00535-y"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00399-6"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108534"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1624"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102701"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/29767342231215178"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2022.100204"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00374-x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdw138"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-3959(00)00047-5"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12979"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7325a1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15641"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100067"},{"key":"e_1_3_3_28_2","unstructured":"Modernizing Opioid Treatment Access Act S. 644 Congress 118th sess (Sen. Markey EJD-M 2023)."},{"key":"e_1_3_3_29_2","unstructured":"The Modernizing Opioid Treatment Access (MOTA) Act: Fact-Checking Sheet. 2023. Accessed November 1 2025. https:\/\/www.aatod.org\/wp-content\/uploads\/2023\/06\/MOTAA-Fact-Sheet_FINAL3.2023-1.pdfopen"},{"key":"e_1_3_3_30_2","unstructured":"Medication Units and Mobile Units. 10A NCAC 27G 3605(2025). Accessed November 15 2025. https:\/\/www.ncdhhs.gov\/dhhs2025-05-09-fiscal-note-rule-10a-ncac-27g-3605-5-9-25\/download?attachment"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2026.209942"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0594-7"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50"},{"key":"e_1_3_3_34_2","unstructured":"USDA. 2020 Rural-Urban Commuting Area Codes. Accessed April 28 2026. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2025.00344"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00563-w"},{"key":"e_1_3_3_37_2","unstructured":"Ostrach B Shubel C Carpenter DM Marley GT. \u201cMethadone at the pharmacy like Suboxone\u00ae?... It would untangle a lot of tangles.\u201d \u2013 Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies. Subst Use Misuse. In press."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/29767342241262115"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2026.100413"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/29767342251377189"},{"key":"e_1_3_3_41_2","unstructured":"NCDHHS. State-funded opioid treatment program services. Accessed November 15 2025. https:\/\/www.ncdhhs.gov\/state-funded-opioid-treatment-program-services-10-15-23\/open"},{"key":"e_1_3_3_42_2","unstructured":"Update Opioid Abatement Treatment Prog. Rules. HB681 General Assembly of North Carolina 2025 sess (2025). Accessed November 15 2025. https:\/\/www.ncleg.gov\/BillLookup\/2025\/H681"},{"key":"e_1_3_3_43_2","unstructured":"Pew. Overview of opioid treatment program regulations by state. Accessed July 31 2025. https:\/\/www.pew.org\/en\/research-and-analysis\/issue-briefs\/2022\/09\/overview-of-opioid-treatment-program-regulations-by-state"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03700.x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2016.1100960"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2025.102348"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100082"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100091"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109518"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.2196\/29575"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016242"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12570"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342261449037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342261449037","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342261449037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:17:50Z","timestamp":1780561070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342261449037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":51,"alternative-id":["10.1177\/29767342261449037"],"URL":"https:\/\/doi.org\/10.1177\/29767342261449037","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"article-number":"29767342261449037"}}